A Study of SH-1028 Tablets Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

NCT04239833 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: SH-1028 tablets
DRUG: Placebo SH-1028 tablets
DRUG: Gefitinib
DRUG: Placebo Gefitinib

Sponsor

Nanjing Sanhome Pharmaceutical, Co., Ltd.